Tracking eye cancer patients for 5 years after experimental treatment
Disease control
Not yet recruiting
This study follows 100 people for about 5 years after they completed a previous trial testing bel-sar for early eye cancer. Researchers will track long-term safety, treatment effectiveness, and quality of life without giving any new treatments. The goal is to understand how well …
Sponsor: Aura Biosciences • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC